Trazodone Geriatric (65+): Caregiver Administration Guidance

What Trazodone Does and Why It Is Prescribed to Older Adults

Trazodone blocks serotonin 5-HT2A receptors and inhibits serotonin reuptake. At lower doses (25 to 100 mg), sedation dominates because histamine H1 and alpha-1 adrenergic antagonism takes over. At higher doses (150 to 400 mg), antidepressant effects become clinically meaningful. Prescribers choose it for older adults partly because it lacks the anticholinergic burden of tricyclics and the QTc-prolonging risk of some SSRIs at equivalent antidepressant doses.

The FDA approved trazodone for major depressive disorder in 1981. Its off-label use for insomnia in older adults has grown substantially; a 2021 JAMA Internal Medicine analysis found trazodone was the second most commonly prescribed sleep agent in U.S. Adults aged 65 and older, behind only zolpidem [1].

Why Age Matters for Pharmacokinetics

Hepatic clearance slows with age. The half-life of trazodone extends to roughly 14 hours in adults over 65, compared with 5 to 9 hours in younger populations [2]. That means a dose given at 9 p.m. May still suppress alertness and blood pressure at 11 a.m. The next morning.

Protein binding also changes. Older adults often have lower albumin levels, which can raise free (active) drug concentrations even when the total measured level looks normal.

Approved vs. Off-Label Uses in This Population

For depression, the American Association for Geriatric Psychiatry supports trazodone as an alternative when SSRIs are not tolerated. For insomnia, no FDA-approved indication exists, but the 2023 American Academy of Sleep Medicine clinical practice guideline states that "evidence supports the use of trazodone for sleep-onset and sleep-maintenance insomnia in adults," though effect sizes are modest [3].

How to Administer Trazodone Correctly

Step-by-Step Dosing for Caregivers

Start with 25 to 50 mg by mouth at bedtime. Give the tablet immediately after a light snack or small meal; food increases bioavailability by roughly 20% and slows absorption, reducing peak sedation spikes [2].

Do not crush extended-release formulations (Oleptro). Immediate-release generic tablets may be split on a scored line if the prescriber specifies a half-tablet dose.

The prescriber will typically titrate by 25 to 50 mg every one to two weeks, watching for tolerance and adverse effects before each increase. The maximum dose for depression in older adults is generally 300 mg per day (divided), though some guidelines suggest staying below 200 mg when the primary goal is sleep.

Timing and Positioning

Give the dose 30 minutes before the patient's intended sleep time. Sit the patient upright for at least 10 minutes after swallowing, then assist them to bed. If they need to use the bathroom within the first four hours, walk beside them. Orthostatic hypotension, the most common serious side effect in this age group, peaks during that window.

A 2019 cohort study in the BMJ (N=503,379 older adults) found that trazodone was associated with a fall-related fracture risk comparable to Z-drugs (adjusted hazard ratio 1.24, 95% CI 1.15 to 1.34) during the first 30 days of use [4].

Missed Dose Protocol

If a bedtime dose is missed and the patient wakes up asking about it, skip the dose entirely. Never double the next dose. Trazodone's long half-life in this age group means a morning "catch-up" dose can cause dangerous daytime drowsiness and blood pressure drops.

Fall Risk Management

Falls are the leading cause of injury-related death in adults aged 65 and older in the United States, accounting for more than 38,000 deaths per year according to CDC data [5]. Trazodone's sedation and alpha-1 blockade both contribute to fall risk, and caregivers are the primary safety net.

Environmental Changes to Make Before the First Dose

• Remove loose rugs in the path from bed to bathroom.
• Install a nightlight or motion-sensor light along that route.
• Place a bedside commode if the bathroom is more than 10 steps away.
• Lower the bed to the lowest safe position.
• Confirm the call button, phone, or alert device is within reach from the bed.

Monitoring Blood Pressure at Home

Take a seated blood pressure reading, then stand the patient and recheck at one minute and three minutes. A drop of 20 mmHg or more in systolic pressure, or 10 mmHg or more in diastolic pressure, meets the clinical definition of orthostatic hypotension [6]. Document readings at baseline, after the first dose, and after every dose increase. Share the log with the prescriber at each visit.

When to Use a Gait Belt

Any patient who was unsteady before starting trazodone, or who shows new unsteadiness within the first week of treatment, should be assisted with a gait belt for all nighttime ambulation. This is not optional caution. A single fall in a 75-year-old with osteoporosis can be life-altering.

Drug Interactions Caregivers Must Know

Trazodone's interaction profile is broad in older adults because polypharmacy is nearly universal in this population. The average Medicare beneficiary takes five or more prescription drugs simultaneously [7].

CNS Depressants

Combining trazodone with benzodiazepines, opioids, gabapentinoids, or other sedating antihistamines multiplies sedation and respiratory depression risk. If the patient is already on any of these agents, ask the prescriber to document the risk-benefit rationale in writing before starting trazodone.

Serotonergic Drugs

Trazodone added on top of an SSRI, SNRI, linezolid, tramadol, or certain triptans raises the risk of serotonin syndrome. Signs include agitation, tremor, clonus (rhythmic muscle jerking), diaphoresis, and hyperthermia. These can develop within hours of adding a new serotonergic agent. If any of these signs appear, call 911, do not wait.

The FDA prescribing information for trazodone explicitly warns: "The concomitant use of trazodone with other serotonergic drugs... Increases the risk of serotonin syndrome" [2].

CYP3A4 Inhibitors

Trazodone is metabolized primarily by CYP3A4. Drugs that inhibit this enzyme, including ketoconazole, ritonavir, clarithromycin, and grapefruit juice, can double or triple plasma trazodone concentrations. If any new medication is added to the patient's regimen, ask the pharmacist to run an interaction check before the first dose.

Antihypertensives

Alpha-1 blockers used for benign prostatic hyperplasia, such as tamsulosin or terazosin, have additive hypotensive effects with trazodone. Men on both drugs need blood pressure monitoring after each dose adjustment of either agent.

Cognitive and Neuropsychiatric Monitoring

Confusion and Delirium

Trazodone's alpha-1 and H1 blockade can precipitate or worsen delirium in older adults, particularly those with pre-existing dementia or mild cognitive impairment. The 2023 American Geriatrics Society Beers Criteria designates trazodone as a drug to use with caution in older adults due to its potential to increase risk of orthostasis, falls, and delirium [8].

Document a brief daily orientation check during the first two weeks: ask the patient today's date, their location, and the name of a family member. If two out of three are wrong on any day where they were previously correct, contact the prescriber that day.

Mood Changes and Suicidality

The FDA requires a black-box warning on all antidepressants, including trazodone, noting increased risk of suicidal thinking and behavior in patients up to age 24. In adults 65 and older, the same analysis found antidepressants were associated with a reduced risk relative to placebo. Still, any new verbalization of self-harm, hopelessness, or giving away possessions should prompt an urgent call to the prescriber or a crisis line (988 in the United States).

Tracking Antidepressant Response

If trazodone is prescribed for depression rather than insomnia, therapeutic response typically takes four to six weeks at an adequate dose. Use a validated tool such as the PHQ-9 every two weeks. Share the scores with the clinical team. A PHQ-9 score reduction of five points or more is considered a clinically meaningful response.

Medical Emergencies Requiring Immediate Action

Priapism

Trazodone causes priapism (prolonged, painful erection unrelated to sexual arousal) in a small but significant number of male patients, estimated at 1 in 6,000 to 1 in 10,000 based on post-marketing surveillance data [2]. An erection lasting more than two hours is a urological emergency. Call 911. Delayed treatment can result in permanent erectile dysfunction. This risk is not limited to the first dose; cases have been reported weeks into therapy.

Serotonin Syndrome

As described above, early symptoms include restlessness, rapid heart rate, muscle twitching, and excessive sweating. This can progress to hyperthermia and seizures within hours. Call 911 immediately and tell the dispatcher the patient is on trazodone and another serotonergic medication.

Severe Cardiac Events

Trazodone produces modest QTc prolongation at high doses. Patients with a known prolonged QT interval, hypokalemia, or who are taking other QTc-prolonging drugs (certain antibiotics, antipsychotics, antiarrhythmics) need a baseline ECG before starting. The FDA label advises caution in patients with pre-existing cardiac disease [2]. New palpitations, syncope, or chest pain warrant same-day evaluation.

Practical Caregiver Communication Checklist

The following framework helps caregivers organize every interaction with the clinical team around trazodone use. Print it, keep it in the medication binder, and bring it to each appointment.

Before the first dose, confirm with the prescriber:

• The exact dose in milligrams and the formulation (immediate-release vs. Extended-release).
• Whether the tablet can be split or must be swallowed whole.
• Which existing medications were reviewed for interactions.
• The target goal: sleep, depression, or both.
• The phone number and after-hours contact for urgent questions.

Each evening at administration:

• Record time of dose, whether food was taken, and any complaints.
• Note the patient's mental status (alert, confused, drowsy).
• Confirm the bedroom path is clear and the nightlight is on.

Each morning for the first two weeks:

• Record whether the patient slept, woke during the night, or had trouble rising.
• Perform the orthostatic blood pressure check.
• Note any new bruising (may signal a fall during the night that was not reported).

At every prescriber visit:

• Bring the BP log, the sleep/mood diary, and the PHQ-9 scores.
• Ask whether any dose adjustment is planned and when the next titration window is.
• Request a full medication interaction review if any new drug has been added since the last visit.

Special Situations Caregivers Encounter

Swallowing Difficulties

Dysphagia is common in adults over 75 and in those with neurological conditions. Trazodone immediate-release tablets can be dissolved in a small amount of water if the prescriber approves, though the bitter taste may require mixing with apple juice. Extended-release tablets must never be dissolved or crushed; contact the prescriber to switch formulations.

Caring for Someone With Dementia

A 2021 Cochrane review examining pharmacological interventions for sleep disturbance in dementia found insufficient evidence to recommend any single agent, including trazodone, over non-pharmacological approaches [9]. The review examined six randomized controlled trials. Start with the lowest available dose (25 mg) and set a clear trial period, typically four weeks, before deciding whether to continue. If agitation worsens, this may represent paradoxical excitation; stop the drug and call the prescriber within 24 hours.

Transitioning From Another Sleep Agent

If the patient is stopping zolpidem or another Z-drug to switch to trazodone, the prescriber will usually overlap for three to seven days to avoid rebound insomnia. Do not stop the prior medication abruptly without explicit instructions. Rebound insomnia after Z-drug discontinuation can be severe in older adults, and adding trazodone before the prior drug is tapered may intensify sedation.

When to Expect Steady State

At a fixed dose, trazodone reaches steady-state plasma concentration in approximately five to seven days in older adults. The prescriber cannot fully assess tolerability until steady state is reached. Do not request a dose increase in the first week based on perceived inadequate effect.

Stopping Trazodone Safely

Trazodone does not cause the physical dependence seen with benzodiazepines, but abrupt discontinuation after weeks of use can cause rebound insomnia, irritability, and nausea. The prescriber should taper the dose over at least one to two weeks. A typical taper reduces the dose by 25 to 50 mg every five to seven days.

Document the taper schedule in the medication binder. If the patient resists reducing the dose because they fear sleep loss, involve the prescriber in that conversation directly. Behavioral interventions for insomnia, specifically Cognitive Behavioral Therapy for Insomnia (CBT-I), have a stronger long-term evidence base than any pharmacological agent in older adults, as confirmed by a meta-analysis of 37 trials published in Annals of Internal Medicine [10].